BEUDAMED
    FDA PMA FDA Class 3 Approved 🇺🇸 United States

    Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode

    PMA: P080006 · Supplement: S063 · Decision May 15, 2014
    View on FDA
    Classifications
    1
    FEI Numbers
    22
    Registration Numbers
    22

    Basic Information

    Device Name
    Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
    Trade Name
    ATTAIN ABILITY MODEL 4X96 LEAD
    PMA Number
    P080006
    Supplement Number
    S063
    Device Class
    FDA Class 3
    Product Code
    OJX
    Generic Name
    Drug eluting permanent left ventricular (lv) pacemaker electrode
    Medical Specialty
    Unknown
    Advisory Committee
    Cardiovascular
    Decision
    Approved
    Decision Code
    APPR
    Decision Date
    May 15, 2014
    Date Received
    November 27, 2013
    Supplement Type
    Normal 180 Day Track
    Supplement Reason
    Change Design/Components/Specifications/Material
    Expedited Review
    N

    Advisory Committee Statement

    APPROVAL FOR CHANGES TO THE MONOLITHIC CONTROLLED RELEASE DEVICE (MCRD) ELUTION METHOD AND SPECIFICATIONS, TRANSFER OF THE MCRD MANUFACTURING LOCATION, USE OF A SURROGATE TIP COMPONENT FOR MCRD TESTING, AND UPDATES TO THE MCRD SHELF LIFE PROTOCOL FOR ATTAIN ABILITY LEAD MODELS 4196, 4296 AND 4396.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    OJX Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode